Search - tctmd.com

Displaying 541 - 560 of 993

Sort: Relevancy | Date

News Conference News TCT 2020

STEMI Door-to-Balloon Times Haven’t Suffered During COVID-19: NACMI

Caitlin E. Cox

October 14, 2020

Presentation TCT 2020

TCT 637: Impella-Supported Directional Coronary Atherectomy in High Risk Patients With Reduced Left Ventricular Ejection Fraction

Presenter: Masaru Ishida

October 14, 2020

Presentation TCT 2020

TCT 134: Relative Quality of Life Improvement After Transcatheter Aortic Valve Replacement (TAVR) in Patients With Reduced Ejection Fraction.

Presenter: Hamza Lodhi

October 14, 2020

Presentation TCT 2020

TCT 421: Clinical Outcomes of Catheter-Guided Renal Denervation for the Treatment of Heart Failure With Reduced Ejection Fraction

Presenter: Daniel Garcia

October 14, 2020

Presentation TCT 2020

TCT 422: Effect of Sympathetic Renal Denervation on Heart Failure With Reduced Ejection Fraction: A Systematic Review and Meta-Analysis

Presenter: Syed Mustafa

October 14, 2020

News Conference News HFSA 2020

Splanchnic Nerve Ablation Improves HFpEF Symptoms, QoL in FIH Study

L.A. McKeown

October 12, 2020

News Conference News HFSA 2020

EMBRACE HF: Empagliflozin Cuts PA Pressure in HF With or Without Diabetes

L.A. McKeown

October 09, 2020

More HF Readmissions Among Black People From Deprived Neighborhoods

News Conference News HFSA 2020

TAVR Delays During Pandemic’s Peak Led to Hospitalizations, Deaths

Michael O'Riordan

September 30, 2020

News Daily News

Fewer MACE in Diabetic Patients Taking SGLT2 Inhibitors vs DPP-4 Inhibitors

Shelley Wood

September 30, 2020

News Daily News

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

Michael O'Riordan

September 24, 2020

News Daily News

Recurrent Events After MI Show Enduring Gender, Racial Gaps in Care

Shelley Wood

September 22, 2020

News Daily News

Renal Function Gains Seen in CKD Patients After TAVR

L.A. McKeown

September 15, 2020

News Conference News ESC 2020

Implantation Technique Influences LV Remodeling After TMVR

Todd Neale

September 04, 2020

News Conference News ESC 2020

Dapagliflozin Wins in Patients With CKD

Todd Neale

August 31, 2020

News Conference News ESC 2020

Revascularization Benefits ISCHEMIA Patients With Mild LV Dysfunction or HF

Michael O'Riordan

August 31, 2020

News Conference News ESC 2020

PARALLAX: Mixed Results for Sacubitril/Valsartan in HFpEF

Todd Neale

August 30, 2020

News Conference News ESC 2020

Trimetazidine Safe but Not Protective Long-term After PCI

Caitlin E. Cox

August 30, 2020

News Conference News ESC 2020

EXPLORER-HCM: Mavacamten Improves Exercise Capacity and Functional Class

Michael O'Riordan

August 29, 2020

News Conference News ESC 2020

EMPEROR-Reduced: Empagliflozin Cuts Hospitalizations, CV Mortality in HFrEF

Michael O'Riordan

August 28, 2020

Advertisement

STEMI Door-to-Balloon Times Haven’t Suffered During COVID-19: NACMI

TCT 637: Impella-Supported Directional Coronary Atherectomy in High Risk Patients With Reduced Left Ventricular Ejection Fraction

TCT 134: Relative Quality of Life Improvement After Transcatheter Aortic Valve Replacement (TAVR) in Patients With Reduced Ejection Fraction.

TCT 421: Clinical Outcomes of Catheter-Guided Renal Denervation for the Treatment of Heart Failure With Reduced Ejection Fraction

TCT 422: Effect of Sympathetic Renal Denervation on Heart Failure With Reduced Ejection Fraction: A Systematic Review and Meta-Analysis

Splanchnic Nerve Ablation Improves HFpEF Symptoms, QoL in FIH Study

EMBRACE HF: Empagliflozin Cuts PA Pressure in HF With or Without Diabetes

More HF Readmissions Among Black People From Deprived Neighborhoods

TAVR Delays During Pandemic’s Peak Led to Hospitalizations, Deaths

Fewer MACE in Diabetic Patients Taking SGLT2 Inhibitors vs DPP-4 Inhibitors

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

Recurrent Events After MI Show Enduring Gender, Racial Gaps in Care

Renal Function Gains Seen in CKD Patients After TAVR

Implantation Technique Influences LV Remodeling After TMVR

Dapagliflozin Wins in Patients With CKD

Revascularization Benefits ISCHEMIA Patients With Mild LV Dysfunction or HF

PARALLAX: Mixed Results for Sacubitril/Valsartan in HFpEF

Trimetazidine Safe but Not Protective Long-term After PCI

EXPLORER-HCM: Mavacamten Improves Exercise Capacity and Functional Class

EMPEROR-Reduced: Empagliflozin Cuts Hospitalizations, CV Mortality in HFrEF

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content